2018
DOI: 10.1002/14651858.cd013090
|View full text |Cite
|
Sign up to set email alerts
|

Xiao Chai Hu Tang, a Chinese herbal medicine formula, for chronic hepatitis B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 75 publications
0
4
0
Order By: Relevance
“…30,31 Moreover, reducing the risk of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, improving quality of life and prolonging survival is the aim of the long-term treatment of chronic hepatitis B. 32,34 The impacts of Hepatitis B virus (HBV) infection can be lifelong as the disease can become chronic and develop further into cirrhosis, liver failure and hepatocellular carcinoma (HCC). The regions of highest prevalence for HBV infection are Africa, the Pacific region and Asia, where the virus is acquired mainly through perinatal transmission.…”
Section: Viral Hepatitismentioning
confidence: 99%
“…30,31 Moreover, reducing the risk of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, improving quality of life and prolonging survival is the aim of the long-term treatment of chronic hepatitis B. 32,34 The impacts of Hepatitis B virus (HBV) infection can be lifelong as the disease can become chronic and develop further into cirrhosis, liver failure and hepatocellular carcinoma (HCC). The regions of highest prevalence for HBV infection are Africa, the Pacific region and Asia, where the virus is acquired mainly through perinatal transmission.…”
Section: Viral Hepatitismentioning
confidence: 99%
“…Below, in accordance with our protocol (Kong 2018), all outcomes are presented with the random-effects model meta-analysis.…”
Section: E Ects Of Interventionsmentioning
confidence: 99%
“…We performed our systematic review based on recommended methodology (Higgins 2019). We followed our prepublished and peer-reviewed protocol with predefined participants, interventions, comparisons, and outcomes to avoid biases in the review process (Kong 2018). We performed comprehensive search strategies which covered published studies and registered study protocols.…”
Section: Potential Biases In the Review Processmentioning
confidence: 99%
“…Before the 2016 Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) harms checklist was published [2], most systematic review guidance was directed toward the evaluation of efectiveness. Most systematic reviews focused on the efectiveness of TCM interventions [3][4][5][6][7][8][9][10]. With concerns about drug safety issues, systematic reviews and meta-analyses of clinical trial safety data have become more important [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%